Evaluating the bioequivalence of clopidogrel generic formulations

Curr Med Res Opin. 2015 May;31(5):861-4. doi: 10.1185/03007995.2015.1028912. Epub 2015 Apr 1.

Authors

M E Tsoumani¹, I V Ntalas, J A Goudevenos, A D Tselepis

Affiliation

¹ Atherothrombosis Research Centre, Laboratory of Biochemistry, Department of Chemistry, University of Ioannina , Ioannina , Greece.

PMID: 25764150
DOI: 10.1185/03007995.2015.1028912

No abstract available

Keywords: Antiplatelet agents; Clopidogrel; Generics; Risk of bleeding.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Chemistry, Pharmaceutical
Clopidogrel
Drugs, Generic / administration & dosage
Drugs, Generic / pharmacokinetics*
Humans
Platelet Aggregation Inhibitors / administration & dosage
Platelet Aggregation Inhibitors / pharmacokinetics*
Therapeutic Equivalency
Ticlopidine / administration & dosage
Ticlopidine / analogs & derivatives*
Ticlopidine / pharmacokinetics

Substances

Drugs, Generic
Platelet Aggregation Inhibitors
Clopidogrel
Ticlopidine